Edition:
India

Mead Johnson Nutrition Co (MJN.N)

MJN.N on New York Stock Exchange

83.22USD
27 May 2016
Change (% chg)

$0.40 (+0.48%)
Prev Close
$82.82
Open
$82.82
Day's High
$83.47
Day's Low
$82.82
Volume
187,471
Avg. Vol
528,898
52-wk High
$97.89
52-wk Low
$65.53

MJN.N

Chart for MJN.N

About

Mead Johnson Nutrition Company (Mead Johnson) is a pediatric nutrition company. The Company manufactures, distributes and sells infant formulas, children's nutrition and other nutritional products. The Company operates through three segments: Asia, North America/Europe and Latin America. Its product portfolio includes routine... (more)

Overall

Beta: 1.09
Market Cap(Mil.): $15,534.17
Shares Outstanding(Mil.): 186.66
Dividend: 0.41
Yield (%): 1.98

Financials

  MJN.N Industry Sector
P/E (TTM): 31.59 26.33 45.15
EPS (TTM): 2.63 -- --
ROI: 19.68 10.30 50.83
ROE: 3,222.43 13.76 56.78

BRIEF-Peoples Bancorp says David Mead elected chairman of board

* Peoples Bancorp Inc. announces retirement of Richard Ferguson from board of directors; David L. Mead elected chairman of the board

20 May 2016

U.S. RESEARCH ROUNDUP-Apple, Intel, Coca-Cola, Macerich

Jan 12 Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including Interactive Brokers Group and UDR Inc, on Tuesday. HIGHLIGHTS * Apple : BofA Merrill raises to buy from neutral * Intel Corp : Mizuho Securities raises to buy; raises target price to $37 * Coca-Cola Co : Stifel raises to buy from hold * Interactive Brokers Group Inc : Goldman Sachs cuts to sell from neutral * UDR Inc : Cowen

12 Jan 2016

Pictet's Aktug likes Mead Johnson Nutrition, sees 14 pct upside

LONDON, Dec 3 Elif Aktug, fund manager at Pictet Asset Management, said she had bought into U.S. company Mead Johnson Nutrition and expected it to rise at least 14 percent in the coming months.

03 Dec 2015

Competitors

  Price Chg
Nestle SA (NESN.S) CHF74.15 --
Abbott Laboratories (ABT.N) $39.30 +0.41
Danone SA (DANO.PA) €63.56 --
Pfizer Inc. (PFE.N) $34.61 +0.18

Earnings vs. Estimates